[{"NetIncomeLoss_1_Q1_USD":-113163000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":52.76,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-461000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-167898000.0,"Depreciation_1_Q1_USD":2700000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":222175000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":43.31,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":882558.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":3000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":552000.0,"AssetsCurrent_0_Q1_USD":1832359000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-2064000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":49864000.0,"FairValueNetAssetLiability_0_Q1_USD":16000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9635636.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":9784000.0,"TreasuryStockValue_0_Q1_USD":63000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":400000.0,"CommonStockSharesIssued_0_Q1_shares":75925944.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":680144000.0,"Assets_0_Q1_USD":1957910000.0,"ShareBasedCompensation_1_Q1_USD":22092000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":50129000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":214592000.0,"CommonStockParOrStatedValuePerShare_0_Q1_CHF":0.03,"TreasuryStockShares_0_Q1_shares":195316.0,"CommitmentsAndContingencies_0_Q1_USD":null,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":473700000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":24517000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":90565000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":52.76,"EarningsPerShareBasic_1_Q1_USD":-1.51,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":75005187.0,"AccountsReceivableNetCurrent_0_Q1_USD":150000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":575000.0,"CommonStockValue_0_Q1_USD":2340000.0,"OtherNonoperatingIncome_1_Q1_USD":1955000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5770000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":2715000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":69404.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.005,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":225991000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":163101000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-113541000.0,"OtherAssetsNoncurrent_0_Q1_USD":6498000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1126059000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":49408000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2490421000.0,"Liabilities_0_Q1_USD":152412000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":11399000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-383000.0,"MarketableSecuritiesCurrent_0_Q1_USD":680144000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":31.48,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":5068000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-539000.0,"CommonStockSharesAuthorized_0_Q1_shares":115172786.0,"OperatingIncomeLoss_1_Q1_USD":-114543000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":323975000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":8572663.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":23881000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-378000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":39000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-112588000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":22092000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":5000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-100663000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":75005187.0,"LiabilitiesCurrent_0_Q1_USD":83090000.0,"RestrictedCashNoncurrent_0_Q1_USD":16844000.0,"AccountsPayableCurrent_0_Q1_USD":13072000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":26006000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":5000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":6784000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1363000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":631890000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":1142903000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":342471.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":167000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":8847000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":51913000.0,"NonoperatingIncomeExpense_1_Q1_USD":1955000.0,"EarningsPerShareDiluted_1_Q1_USD":-1.51,"CommonStockSharesOutstanding_0_Q1_shares":75730628.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":6000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1802000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":139.05,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":33.12,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1957910000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":11565000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":22092000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":191300000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":75794000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":12063000.0,"OperatingExpenses_1_Q1_USD":115082000.0,"ProfitLoss_1_Q1_USD":-113163000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":8138000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2933000.0,"StockholdersEquity_0_Q1_USD":1805498000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":11776000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":7024000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":680657000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-3766000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":8572663.0,"TaxesPayableCurrent_0_Q1_USD":3356000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3962897.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-686739000.0,"PropertyPlantAndEquipmentFairValueDisclosure_0_Q1_USD":9340000.0,"MarketableSecurities_0_Q1_USD":494200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-42565000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":539000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1874000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210427"}]